Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Product
1.1.3. Accessories
1.1.4. End use
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Product outlook
2.2.3. Accessories outlook
2.2.4. End use outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Insulin pumps Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Insulin pumps Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Insulin pumps Market: Type Estimates & Trend Analysis
4.1. Insulin pumps Market: Key Takeaways
4.2. Insulin pumps Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Patch pumps
4.3.1. Patch pumps market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Tethered pumps
4.4.1. Tethered pumps market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Insulin pumps Market: Product Estimates & Trend Analysis
5.1. Insulin pumps Market: Key Takeaways
5.2. Insulin pumps Market: Movement & Market Share Analysis, 2022 & 2030
5.3. MiniMed (630G, 670G, and VEO)
5.3.1. MiniMed (630G, 670G, and VEO) market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Accu-Chek (combo, insight, and solo)
5.4.1. Accu-Chek (combo, insight, and solo) market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Tandem (T: SLIM X2, G4, T: flex delivery system)
5.5.1. Tandem (T: SLIM X2, G4, T: flex delivery system) market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Omnipod
5.6.1. Omnipod market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. My life omnipod
5.7.1. My life omnipod market estimates and forecasts, 2018 to 2030 (USD Million)
5.8. Others
5.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Insulin pumps Market: Accessories Estimates & Trend Analysis
6.1. Insulin pumps Market: Key Takeaways
6.2. Insulin pumps Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Insulin reservoir or cartridges
6.3.1. Insulin reservoir or cartridges market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Insulin set insertion devices
6.4.1. Insulin set insertion devices market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Batteries
6.5.1. Batteries market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Insulin pumps Market: End Use Estimates & Trend Analysis
7.1. Insulin pumps Market: Key Takeaways
7.2. Insulin pumps Market: Movement & Market Share Analysis, 2022 & 2030
7.3. Hospitals & clinics
7.3.1. Hospitals & clinics market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Homecare
7.4.1. Homecare market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Laboratories
7.5.1. Batteries market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Insulin pumps Market: Regional Estimates & Trend Analysis
8.1. Regional Outlook
8.2. Insulin pumps Market by Region: Key Marketplace Takeaway
8.3. North America
8.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.3.2. U.S.
8.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.3.3. Canada
8.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4. Europe
8.4.1. UK
8.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.2. Germany
8.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.3. France
8.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.4. Italy
8.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.5. Spain
8.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.6. Sweden
8.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.7. Norway
8.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.8. Denmark
8.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.2. China
8.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.3. India
8.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.4. Australia
8.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.5. Thailand
8.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.6. South Korea
8.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.6.2. Mexico
8.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.6.3. Argentina
8.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7. MEA
8.7.1. Saudi Arabia
8.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7.2. South Africa
8.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7.3. UAE
8.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7.4. Kuwait
8.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.2.1. Medtronic plc
9.2.1.1. Company overview
9.2.1.2. Financial performance
9.2.1.3. Product benchmarking
9.2.1.4. Strategic initiatives
9.2.2. Hoffmann-La Roche Ltd
9.2.2.1. Company overview
9.2.2.2. Financial performance
9.2.2.3. Product benchmarking
9.2.2.4. Strategic initiatives
9.2.3. Tandem Diabetic Care, Inc.
9.2.3.1. Company overview
9.2.3.2. Financial performance
9.2.3.3. Product benchmarking
9.2.3.4. Strategic initiatives
9.2.4. Insulet Corporation
9.2.4.1. Company overview
9.2.4.2. Financial performance
9.2.4.3. Product benchmarking
9.2.4.4. Strategic initiatives
9.2.5. Ypsomed
9.2.5.1. Company overview
9.2.5.2. Financial performance
9.2.5.3. Product benchmarking
9.2.5.4. Strategic initiatives
9.2.6. Cellenovo
9.2.6.1. Company overview
9.2.6.2. Financial performance
9.2.6.3. Product benchmarking
9.2.6.4. Strategic initiatives
9.2.7. Sooil Development
9.2.7.1. Company overview
9.2.7.2. Financial performance
9.2.7.3. Product benchmarking
9.2.7.4. Strategic initiatives
9.2.8. Valeritas, Inc
9.2.8.1. Company overview
9.2.8.2. Financial performance
9.2.8.3. Product benchmarking
9.2.8.4. Strategic initiatives
9.2.9. JingasuDelfu Co., Ltd.
9.2.9.1. Company overview
9.2.9.2. Financial performance
9.2.9.3. Product benchmarking
9.2.9.4. Strategic initiatives
|
